Viewpoint Capital Management LLC Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Viewpoint Capital Management LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) during the 4th quarter, Holdings Channel.com reports. The firm bought 2,000 shares of the exchange traded fund’s stock, valued at approximately $180,000.

Several other institutional investors have also recently bought and sold shares of XBI. Golden State Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $29,000. Avior Wealth Management LLC lifted its stake in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares in the last quarter. Tidemark LLC lifted its stake in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $40,000. Finally, ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $44,000.

SPDR S&P Biotech ETF Stock Down 1.4 %

NYSEARCA:XBI opened at $89.05 on Wednesday. The firm has a market capitalization of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock’s 50 day moving average price is $92.23 and its two-hundred day moving average price is $96.30.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.